Is SPCX or JNJ a better dividend investment in 2026?

SPCX currently yields 16.37% with a 5% 5-year dividend growth rate. JNJ yields 3.36% with 5.8% growth. The better choice depends on your goal: SPCX offers higher current income.

What is the dividend yield difference between SPCX and JNJ?

SPCX has a forward dividend yield of 16.37% ($3.59/share annually). JNJ yields 3.36% ($4.96/share annually). The yield gap is 13.01 percentage points.

Home › Compare › SPCX vs JNJ

SPCX vs JNJ: Dividend Comparison 2026

SPCX yields 16.37% · JNJ yields 3.36%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 SPCX wins by $38.3K in total portfolio value

INVESTMENT

TIME HORIZON10 years

SPCX

● Live price

16.37%

Share price

$21.94

Annual div

$3.59

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$58.3K

Annual income

$4,475.89

Full SPCX calculator →

JNJ

Johnson & Johnson

● Live price

3.36%

Share price

$147.50

Annual div

$4.96

5Y div CAGR

5.8%

Payout ratio

55%

After 10 yrs · $10,000 · DRIP

Portfolio value

$20.0K

Annual income

$827.78

Full JNJ calculator →

Portfolio growth — SPCX vs JNJ

📍 SPCX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	SPCX	JNJ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, SPCX + JNJ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

SPCX pays

JNJ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SPCX

Annual income on $10K today (after 15% tax)

$1,391.04/yr

After 10yr DRIP, annual income (after tax)

$3,804.51/yr

JNJ

Annual income on $10K today (after 15% tax)

$285.83/yr

After 10yr DRIP, annual income (after tax)

$703.61/yr

At 15% tax rate, SPCX beats the other by $3,100.89/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SPCX + JNJ for your $10,000?

SPCX: 50%JNJ: 50%

100% JNJ50/50100% SPCX

Portfolio after 10yr

$39.1K

Annual income

$2,651.83/yr

Blended yield

6.77%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

SPCX

No analyst data

JNJ

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$228.73

+55.1% upside vs current

Range: $190.00 — $265.00

Altman Z

5.2

Piotroski

4/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SPCX buys

JNJ buys

No recent congressional trades found for SPCX or JNJ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricSPCXJNJ

Forward yield	16.37% ✓	3.36%
Annual dividend / share	$3.59	$4.96 ✓
Payout ratio	50% ✓	55%
1-year div growth	0%	4.2% ✓
5-year div CAGR	0%	5.8% ✓
Portfolio after 10y	$58.3K ✓	$20.0K
Annual income after 10y	$4,475.89 ✓	$827.78
Total dividends collected	$29.7K ✓	$5.6K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: SPCX vs JNJ ($10,000, DRIP)

Year	SPCX Portfolio	SPCX Income/yr	JNJ Portfolio	JNJ Income/yr	Gap
1← crossover	$12,337	$1,636.52	$10,676	$355.77	+$1.7K → SPCX
2	$15,087	$1,886.82	$11,407	$389.39	+$3.7K → SPCX
3	$18,300	$2,156.53	$12,198	$426.53	+$6.1K → SPCX
4	$22,025	$2,444.61	$13,056	$467.62	+$9.0K → SPCX
5	$26,317	$2,749.82	$13,987	$513.12	+$12.3K → SPCX
6	$31,230	$3,070.68	$14,998	$563.56	+$16.2K → SPCX
7	$36,821	$3,405.53	$16,098	$619.52	+$20.7K → SPCX
8	$43,151	$3,752.60	$17,295	$681.69	+$25.9K → SPCX
9	$50,282	$4,110.03	$18,599	$750.82	+$31.7K → SPCX
10	$58,277	$4,475.89	$20,022	$827.78	+$38.3K → SPCX

SPCX vs JNJ: Complete Analysis 2026

SPCX — Stock

In pursuing the fund's investment objective, the fund will invest at least 80% of its net assets (plus any borrowings for investment purposes) in units and shares of Special Purpose Acquisitions Companies (“SPACs”) that have a minimum capitalization of $100 million and companies that completed an initial public offering (“IPO”) within the last two years. The fund may also invest in depositary receipts for cash management purposes or due to a lack of suitable investment opportunities, the fund may hold up to 20% of its net assets in cash or similar short-term, high-quality debt securities.

Full SPCX Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →

📬

Get this SPCX vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SPCX vs SCHD SPCX vs JEPI SPCX vs O SPCX vs KO SPCX vs MAIN SPCX vs ABBV SPCX vs MRK SPCX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.